May 19th Biotech Update

A little pullback to consolidate is fine.  The absolutely semi-crash the other day is something else.  The market is clearly on edge and the sector is included.  The nice thing is that we did not breakdown to new lows and so if we can somehow recover then perhaps we establish a higher low.  I would […]

May 18th Biotech Update

The sector had been strong and that is nice to see.  It was especially interesting to see the sector strength (and market for that matter) when the Fed is talking.   Usually those are guaranteed red days.  Perhaps the sector is becoming a little more immunized against Fed talk.  Of course, just when you think the […]

May 16th Biotech Update

Last week was an interesting one.  We had a lot of hope with the M&A and the strong reaction to it and then disaster as the market continued its weakness and the sector with it.  We then rallied at the end of the week.  Taking a step back and looking and the week overall it […]

May 10th Biotech Update

This should be it.  The sector has been oversold and very stretched to the downside and was due for a bounce.  Today we finally see some significant M&A and this should trigger a nice multi-day rally.  If this deal cannot move the sector in a meaningful way when it is oversold then I do not […]

May 9th Biotech Update

The sector continues to be a complete mess along with the broader market.  We are at multi-year lows and this move lower has been relentless.  I am sounding like a broken record but this has to see a dead cat bounce at some point.  Of course, the one thing the sector has not done is […]

May 3rd Biotech Update

  So we had a late day rally yesterday and I am not sure what to think about it.  I sort of prefer the weak Monday and gap down Tuesday morning to reverse green sort of setups.  It was nice to see the sector rally on what was a group of bad news but with […]

May 2nd Biotech Update

The sector and market continue to do poorly.  We are getting close to at least a short term bottom as the move lower has been pretty quick and relentless.  Obviously the pattern is for these to be pauses before another move lower but the first thing we need is to at least stop the bleeding.  […]

April 29th Biotech Update

We remain stuck in that I think the sector is gong to move with the broader market and the broader market is not good at this point.  I would think both the sector and broader market were oversold in the short term and due for at least a dead cat bounce and yesterday looked to […]

April 28th Biotech Update

Well, the sector and market is a mess right now.  This makes it an interesting earning season as we have to content not just with what the quarterly results are telling us but also in an uncertain economic background.  The US GDP unexpectedly contracted, although it might be overstating the weakness of the economy as […]

April 26th Biotech Update

Sorry I have been away for a bit but life outside of biotech has been very complicated and all consuming.  I am hopefully more able to focus on biotech going forward but we will see.  It seems like the sector has been just as difficult as well and that is disappointing as it was setting […]

April 20th Biotech Update

The sector once again shows it brutal head and what seemed like a nice opportunity to build momentum and excitement to the upside gets reversed.  While we have not broken to new lows we are certainly approaching the bottom of what could be seen as a channel.  The $80s are going to be critical to […]

April 13th Biotech Update

We had a chance to build some nice momentum and yet we failed once again.  To be fair the broader markets have not been that conducive so it is not as if this is a sector specific move but it is yet another disappointment in a long line of disappointments.  The sector can still save […]

April 8th Biotech Update

While it looked like today was going to be a flat week of consolidation, the last couple of days have been a disappointment and this is more of a pullback sort of week.  Pullbacks are not bad per se as long as it stays above support and I think if we stay above $90 and […]

April 7th Biotech Update

It has been an up and down week and while some of the moves felt trend like, i.e. that they would be part of a more sustained move to the upside or downside, it seems like the week is one of sideways.  There are still two trading days to make the week one of green […]

April 6th Biotech Update

We had a good day and then a bad day and hopefully we have another good day.  The sector is doing well (or at least better than it has been for a long time). It has been awhile since the sector looked to be setting up an uptrend and while we have been disappointed before, […]

April 1st Biotech Update

It is not an April Fools Day joke but the sector outperformed the broader markets for the March and I think was even barely green.  While I think we would want more than barely green and would want an even greater outperformance, it has to be a positive sign for the sector to outperform in […]

March 31st Biotech Update

The sector looked like it was going to have a nice continuation day yesterday but the afternoon ended up being a mess.  It is nice to see that it is not continued into this morning but we really do not want to start the pattern of green in the morning only to reverse later in […]

March 30th Biotech Update

The sector has had a good start to the week but we are not getting the big positive news that could really amp the move higher.  As I noted the idea scenario would be this positive momentum to coincide with some sector meaningful positive news but not yet.  This is not to say it is […]

March 25th Biotech Update

Still not a lot of news in the sector.  I am encouraged that we continue to maintain this range and consolidate at these levels.  The key next will be to break out of this range to the upside and ideally it is done on the back of some positive fundamental news (M&A or positive data […]

March 24th Biotech Update

The sector started weak and then had a nice recovery but then reverse back to the downside. I would not read too much into it as we basically remain in the range formed from the last move higher.  As long as we do not make a move back towards the recent lows, we could see […]